Hanmi Pharm presents study results of LAPSCOVERY at ADA

Published: 2017-06-19 10:46:06

Updated: 2017-06-19 10:46:06

2 candidate substances of biologic applied with ‘LAPSCOVERY,’ Hanmi Pharm’s own platform technology, were revealed at the world’s largest diabetes association American Diabetes Association(ADA).

Hanmi Pharm(CEO Sae-Chang Kwon, Jong-Soo Woo) announced on the 14^th the company participated in the 77^th ADA event in San Diego between the 9^th and 13^th and has a poster presentation for 2 cases of stu...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.